Atika Capital Management »

Kymera Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.1M 102k 40.20

More positions owned by Atika Capital Management

EXACT Sciences Corporation Call Option (EXAS)
Ishares Tr Rus Top 200 Etf Call Option (IWL)
NVIDIA Corporation (NVDA)
Shockwave Med
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Inspire Med Sys (INSP)
Amazon (AMZN)
MercadoLibre (MELI)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Rxsight (RXST)
Meta Platforms Cl A (META)
Sentinelone Cl A (S)
Appfolio Com Cl A (APPF)

View all positions for Atika Capital Management

Top funds holding Kymera Therapeutics

T. Rowe Price Associates
Baker Bros. Advisors
Atlas Venture Life Science Advisors
BVF
Vanguard Group
FMR
Wellington Management Company
BlackRock
venBio Select Advisor
Artal Group
State Street Corporation
Redmile Group
Deep Track Capital
Rock Springs Capital Management
Geode Capital Management

View all funds holding Kymera Therapeutics